Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual vs Triple Vonoprazan Therapy for H. pylori
NCT02827942Phase 3Completed
- Sponsor
- Hamamatsu University School of Medicine
- Start
- Jul 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vonoprazan in Helicobacter pylori infection, sponsored by Hamamatsu University School of Medicine. Started Jul 2016; status: completed.
02
Drugs
vonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02827942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02827942.